Gorka R. De Garibay
Barcelona, CT 08908, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.
Journal: Journal for immunotherapy of cancer
Published: July 17, 2022
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Journal: Nature communications
Published: May 20, 2021
Cancer network activity associated with therapeutic response and synergism.
Journal: Genome medicine
Published: May 07, 2016
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
Journal: Oncogene
Published: March 10, 2016
Study of breast cancer incidence in patients of lymphangioleiomyomatosis.
Journal: Breast cancer research and treatment
Published: January 04, 2016
Naturally occurring BRCA2 alternative mRNA splicing events in clinically relevant samples.
Journal: Journal of medical genetics
Published: November 17, 2015
Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing.
Journal: Clinical chemistry
Published: November 12, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants.
Journal: International journal of cancer
Published: August 05, 2013
Capillary electrophoresis analysis of conventional splicing assays: IARC analytical and clinical classification of 31 BRCA2 genetic variants.
Journal: Human mutation
Published: June 17, 2013
Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.
Journal: European journal of human genetics : EJHG
Published: June 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026